A research collaboration headed by a Monash chemist was issued a US-issued patent for an invention that could deliver a more accurate test for malaria that is rapid and low cost, making it suitable for resource-poor environments. The patent is the first of its kind to utilise spectroscopy to quantify pathogens in blood.
The Federal government has announced around $300,000 in funding to Biotech Resources in partnership with the Monash Centre for Biospectroscopy to combat sepsis – one of the leading causes of hospital deaths in Australia.
When Monash chemistry Professor Doug MacFarlane was a PhD student at Purdue University in Indiana, he worked on “liquid salts” for use in preserving living tissue – including human kidneys and marine corals. Fast-forward 30 years and marine biologists are now freezing hundreds of species of corals threatened by global warming in these salts, which are also known as ionic liquids.